-
rather than an R company.
-
The reason is really quite simple.
-
If you look at most food companies, they tend to be driven
-
by very short term objectives demanded by Wall Street,
-
as opposed to the pharmaceutical companies
-
who have a pipeline of research of five to ten years.
-
If we start telling our finance people that we want money from them
-
to go away for ten years and we'll give them solutions,
-
I can tell you they will just walk away after laughing at us.
-
Instead, we need to think about a model that works better
-
for the food industry where research yields results quicker
-
than the cycle of pharmaceutical companies,